Anti-FOXO4/AFX antibody [EPR5442]
- RabMAb
- Recombinant
- 20ul selling size
- What is this?
5
(1 Review)
|
(27 Publications)
Rabbit Recombinant Monoclonal FOXO4/AFX antibody. Suitable for IP, WB, Flow Cyt (Intra) and reacts with Human samples. Cited in 27 publications.
View Alternative Names
AFX, AFX1, MLLT7, FOXO4, Forkhead box protein O4, Fork head domain transcription factor AFX1
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-FOXO4/AFX antibody [EPR5442] (AB128908)
Intracellular flow cytometric analysis of FOXO4/AFX in permeabilized HEK-293T (Human epithelial cell line from embryonic kidney transformed with large T antigen) cells using ab128908 at 1/100 dilution (Red) compared to a non-specific negative control antibody (green).
- IP
Unknown
Immunoprecipitation - Anti-FOXO4/AFX antibody [EPR5442] (AB128908)
Purified ab128908 at 1/100 dilution (2μg) immunoprecipitating FOXO4/AFX in 293T whole cell lysate.
Lane 1 (input) : 293T (Human embryonic kidney epithelial cell) whole cell lysate 10μg
Lane 2 (+) : ab128908 + 293T whole cell lysate.
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab128908 in 293T whole cell lysate.
VeriBlot for IP Detection Reagent (HRP) (ab131366) (1/1000 dilution) was used for Western blotting.
Blocking Buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM/TBST.
Observed band size : 65 kDa
All lanes:
Immunoprecipitation - Anti-FOXO4/AFX antibody [EPR5442] (ab128908)
Predicted band size: 53 kDa
false
- WB
Unknown
Western blot - Anti-FOXO4/AFX antibody [EPR5442] (AB128908)
All lanes:
Western blot - Anti-FOXO4/AFX antibody [EPR5442] (ab128908) at 1/1000 dilution
Lane 1:
293T lysate at 10 µg
Lane 2:
Fetal heart lysate at 10 µg
Lane 3:
Fetal muscle lysate at 10 µg
Lane 4:
Fetal lung lysate at 10 µg
Lane 5:
HuT-78 lysate at 10 µg
Secondary
All lanes:
Goat-anti-rabbit HRP at 1/2000 dilution
Predicted band size: 53 kDa
Observed band size: 65 kDa
false
- WB
Supplier Data
Western blot - Anti-FOXO4/AFX antibody [EPR5442] (AB128908)
Blocking and diluting buffer and concentration : 5% NFDM/TBST The bands above 100 kDa are unknown. In Western blot, anti-FOXO4 antibody (ab128908) staining at 1/1000 dilution. Exposure time : 59 seconds.
All lanes:
Western blot - Anti-FOXO1A (pT24)+FOXO3A (pT32)+FOXO4 (pT28)+FOXO6 (pT26) antibody [EPR28359-78] (<a href='/en-us/products/primary-antibodies/foxo1a-pt24foxo3a-pt32foxo4-pt28foxo6-pt26-antibody-epr28359-78-ab312326'>ab312326</a>) at 1/1000 dilution
Lane 1:
Jurkat (human t cell leukemia t lymphocyte from peripheral blood) starved overnight, then treated with 50 uM LY294092 for 30min whole cell lysate (untreated membrane) at 20 µg
Lane 2:
Jurkat starved overnight, then treated with 20% serum and 100nM Calycin A for 30min whole cell lysate (untreated membrane) at 20 µg
Lane 3:
Jurkat starved overnight, then treated with 20% serum and 100nM Calycin A for 30min whole cell lysate (phosphatase treated membrane) at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 75-80 kDa
false
Exposure time: 59s
- WB
Unknown
Western blot - Anti-FOXO4/AFX antibody [EPR5442] (AB128908)
All lanes:
Western blot - Anti-FOXO4/AFX antibody [EPR5442] (ab128908) at 1/1000 dilution
Lane 1:
293T transfected with FOXO4/AFX
Lane 2:
293T cell lysate
Secondary
All lanes:
Goat-anti-rabbit HRP at 1/2000 dilution
Predicted band size: 53 kDa
Observed band size: 63 kDa
false
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-FOXO4/AFX antibody [EPR5442] (AB128908)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Related conjugates and formulations (3)
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-FOXO4/AFX antibody [EPR5442]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-FOXO4/AFX antibody [EPR5442]
-
Anti-FOXO4/AFX antibody [EPR5442] - BSA and Azide free
Reactivity data
Product details
This antibody was developed as part of a collaboration between the University of Utrecht in the Netherlands and the lab of Tobias Dansen.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This protein influences processes essential for cell survival and metabolism. FOXO4 forms part of the larger forkhead box family of transcription factors. Inside cells it regulates genes involved in mechanisms such as gluconeogenesis and immune responses. It can also interact with other proteins like 14-3-3 which helps control its nuclear-cytoplasmic shuttling impacting its activity.
Pathways
FOXO4 becomes an integral part of the insulin signaling and oxidative stress response pathways. In the insulin pathway FOXO4 activity suppresses in response to insulin signals that trigger the PI3K/Akt pathway. Akt phosphorylates FOXO4 disallowing it from entering the nucleus. FOXO4 relates closely with FOXO1 and FOXO3 within these pathways where their coordinated activities help maintain energy homeostasis and cellular stress responses.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (27)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:1184 PubMed39885127
2025
Applications
Unspecified application
Species
Unspecified reactive species
Developmental biology 504:25-37 PubMed37722500
2023
Applications
Unspecified application
Species
Unspecified reactive species
Pharmacology 108:331-343 PubMed37231990
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 25: PubMed35475577
2022
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineered 13:6080-6091 PubMed35196182
2022
Applications
Unspecified application
Species
Unspecified reactive species
American journal of physiology. Heart and circulatory physiology 322:H417-H426 PubMed35089807
2022
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 297:101426 PubMed34800438
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 24: PubMed34549304
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 24: PubMed34515319
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 24: PubMed34296293
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com